NPS 1506
Action
Glutamate antagonist (NMDA channel blocker)
Status
Phase 1b trial initiated 7/98. "Human clinical trials of NPS 1506 have been put on financial hold while NPS searches for a corporate partner to participate in further development."
Trial(s)


|